Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Translational Neurodegeneration, 2023Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial
Yulug B., Altay O., Li X. et al.
Olink Target 96
Molecular Medicine, 2023Urine-based multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS
Batra R., Uni R., Akchurin O. et al.
Journal of the American Heart Association, 2023High Plasma Levels of Soluble Lectin‐like Oxidized Low‐Density Lipoprotein Receptor‐1 Are Associated With Inflammation and Cardiometabolic Risk Profiles in Pediatric Overweight and Obesity
Stinson S., Jonsson A., Andersen M. et al.
Clinical Proteomics, 2023Are the results from a multiplex proteomic assay and a conventional immunoassay for NT-proBNP and GDF-15 comparable?
Skau E., Wagner P., Leppert J. et al.
European Journal of Preventive Cardiology, 2023Proteomic profiling identifies novel independent relationships between inflammatory proteins and myocardial infarction
Valdes-Marquez E., Clarke R., Hill M. et al.
Med, 2023Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors
Nuñez N., Berner F., Friebel E. et al.
Brain Communications, 2023Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis
Burman J., Zjukovskaja C., Svenningsson A. et al.
Neurotrauma Reports, 2023A Dedicated 21-Plex Proximity Extension Assay Panel for High-Sensitivity Protein Biomarker Detection Using Microdialysis in Severe Traumatic Brain Injury: The Next Step in Precision Medicine?
Dyhrfort P., Wettervik T., Clausen F. et al.
Olink Focus
Clinical Chemistry and Laboratory Medicine (CCLM), 2023Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantation
Pasic I., Ren A., Nampoothiri R. et al.
Cells, 2023Midgut Volvulus Adds a Murine, Neutrophil-Driven Model of Septic Condition to the Experimental Toolbox
Elrod J., Kiwit A., Lenz M. et al.
Olink Target 96 Mouse
Artificial Intelligence in Medicine, 2023Benchmarking of Machine Learning classifiers on plasma proteomic for COVID-19 severity prediction through interpretable artificial intelligence
Dimitsaki S., Gavriilidis G., Dimitriadis V. et al.
Olink Explore 3072/384
Translational Lung Cancer Research, 2023Circulating immune response proteins predict the outcome following disease progression of osimertinib treated epidermal growth factor receptor-positive non-small-cell lung cancer patients
Maansson C., Helstrup S., Ebert E. et al.
Atherosclerosis, 2023Plasma levels of CCL21, but not CCL19, independently predict future coronary events in a prospective population-based cohort
Katra P., Hennings V., Nilsson J. et al.
Translational Psychiatry, 2023Discovery and replication of blood-based proteomic signature of PTSD in 9/11 responders
Waszczuk M., Kuan P., Yang X. et al.
Cell Reports, 2023The human placenta shapes the phenotype of decidual macrophages
Vondra S., Höbler A., Lackner A. et al.
Frontiers in Cardiovascular Medicine, 2023Plasma protein profiling analysis in patients with atrial fibrillation before and after three different ablation techniques
Lin M., Bao Y., Du Z. et al.
Nature Medicine, 2023Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial
Hong D., Van Tine B., Biswas S. et al.
European Journal of Sport Science, 2023Cardiorespiratory fitness and targeted proteomics involved in brain and cardiovascular health in children with overweight/obesity
Plaza‐Florido A., Rodriguez‐Ayllon M., Altmäe S. et al.
Rheumatology, 2023Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages
Rodríguez-Carrio J., Alperi-López M., López P. et al.
International Journal of Molecular Sciences, 2023Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer’s Disease Aetiopathogenesis in Men
García-González P., de Rojas I., Moreno-Grau S. et al.
3144 publications
Items per page
1581-1600 of 3144 publications